Bosiers M, de Donato G, Deloose K, Verbist J, Peeters P, Castriota F, Cremonesi A, Setacci C
Department of Vascular Surgery, AZ St-Blasius, Dendermonde, Belgium.
Eur J Vasc Endovasc Surg. 2007 Feb;33(2):135-41; discussion 142-3. doi: 10.1016/j.ejvs.2006.09.019. Epub 2006 Nov 9.
To identify if carotid stent design, especially free cell area, impacts on the 30-day rates for stroke, death and TIA after carotid artery stenting (CAS).
A CAS database of 3179 consecutive CAS patients was retrospectively assessed. The distribution of neurological complications were analysed for association with the different stent types and designs. Events where subdivided into procedural and postprocedural events.
The overall combined rate of TIA, stroke and death was 2.8% at 30 days (late events 1.9%). The post-procedural event rate analyzed for differences stents varied from 1.2% using BSCI Carotid Wallstent to 5.9% using Medtronic Exponent. The late event rates varied from 1.2% to 3.4% for free cell areas <2.5mm(2) and >7.5mm(2) respectively (p<0.05). Post-procedural event rate was 1.3% for closed cells and 3.4% for open cells. All these differences were highly pronounced among symptomatic patients (p<0.0001).
After carotid stenting, complication rates vary according to stent type, free cell area and cell design. In the symptomatic population (and also in the total population), post-procedural complication rates are highest for the open cell types and increase with larger free cell area.
确定颈动脉支架设计,尤其是自由细胞面积,是否会影响颈动脉支架置入术(CAS)后30天的中风、死亡和短暂性脑缺血发作(TIA)发生率。
对3179例连续接受CAS治疗患者的数据库进行回顾性评估。分析神经并发症的分布情况,以确定其与不同支架类型和设计之间的关联。事件分为手术过程中事件和术后事件。
30天时,TIA、中风和死亡的总体综合发生率为2.8%(晚期事件为1.9%)。不同支架术后事件发生率从使用BSCI颈动脉Wallstent的1.2%到使用美敦力Exponent的5.9%不等。自由细胞面积<2.5mm²和>7.5mm²时,晚期事件发生率分别为1.2%和3.4%(p<0.05)。闭合细胞的术后事件发生率为1.3%,开放细胞为3.4%。所有这些差异在有症状患者中非常显著(p<0.0001)。
颈动脉支架置入术后,并发症发生率因支架类型、自由细胞面积和细胞设计而异。在有症状人群(以及总体人群)中,开放细胞类型的术后并发症发生率最高,且随着自由细胞面积增大而增加。